Source: Annual Congress 2003 - Immunology of interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. E. Tsantes, S. T. Tassiopoulos, A. D. Vlachou, S. A. Bonovas, N. C. Poulakis (Athens, Greece). Serum‘s factors inhibit erythropoiesis in patients with idiopathic pulmonary fibrosis(IPF). Eur Respir J 2003; 22: Suppl. 45, 1519

Member's Comments

No comment yet.

Related content which might interest you: The effect of inferon on oxygen-dependent metabolism of blood cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Effect of metformin on clinically relevant outcomes in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 The relationship of the transcription factors AP-1 and NF-KB with lung function in the lungs of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Bosentan influence on cellular immunity parameters in patients with idiopathic arterial pulmonary hypertension Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Vulnerability of fatal infection under steroid treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012 The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017 Year: 2018 Expression profile of Th1/Th2 transcription factors T-bet and GATA-3 in sarcoidosis, idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Predictor factors of mortality in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 The role of IL-10 receptors in aberrant homeostatic control of TNF-α in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002